Cue Biopharma (FRA:1UC) Short-Term Capital Lease Obligation : €3.31 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Cue Biopharma Short-Term Capital Lease Obligation?

Cue Biopharma's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was €3.31 Mil.

Cue Biopharma's quarterly Short-Term Capital Lease Obligation increased from Sep. 2024 (€2.61 Mil) to Dec. 2024 (€3.38 Mil) but then declined from Dec. 2024 (€3.38 Mil) to Mar. 2025 (€3.31 Mil).

Cue Biopharma's annual Short-Term Capital Lease Obligation declined from Dec. 2022 (€3.12 Mil) to Dec. 2023 (€3.09 Mil) but then increased from Dec. 2023 (€3.09 Mil) to Dec. 2024 (€3.38 Mil).

Cue Biopharma Short-Term Capital Lease Obligation Historical Data

The historical data trend for Cue Biopharma's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cue Biopharma Short-Term Capital Lease Obligation Chart

Cue Biopharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

3.93

4.37

3.12

3.09

3.38

Cue Biopharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															2.95	2.84	2.61	3.38	3.31

Cue Biopharma Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Cue Biopharma Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Cue Biopharma's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Cue Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cue Biopharma Inc (FRA:1UC) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

CUE:USA 1UC:Germany

Address

40 Guest Street, Boston, MA, USA, 02135

Website

https://www.cuebiopharma.com

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Cue Biopharma Headlines

No Headlines